Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study
在既往接受过治疗的微卫星不稳定性高/错配修复缺陷型转移性结直肠癌患者中，使用纳武利尤单抗联合瑞拉利单抗治疗：II期CheckMate 142研究
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-008689
Overman, Michael J; Gelsomino, Fabio; Aglietta, Massimo; Wong, Mark; Limon Miron, Maria Luisa; Leonard, Gregory; García-Alfonso, Pilar; Hill, Andrew G; Cubillo Gracian, Antonio; Van Cutsem, Eric; El-Rayes, Bassel; McCraith, Stephen M; He, Beilei; Lei, Ming; Lonardi, Sara
